At least not Down Under. Today’s post comes to us from John Seng, Founder and CEO of GLOBALHealthPR US Partner and Chair, Spectrum.
Traveling down the south coast of Australia following our GLOBALHealthPR annual meeting several weeks ago, I stopped in at a NewsPower store in Bateman’s Bay to look for a souvenir or two for family members, plus to satisfy a little curiosity about what Aussies read today.
Here in Sydney, we’ve just concluded our 2014 Annual General Meeting (AGM), the first to be hosted in Australia by our partners at VIVA! Communications. And, we could not be more excited about the outcomes! Early on, we got a heavy dose of local in-country updates from GLOBALHealthPR members, who reflected on accomplishments and challenges alike. Next, we used these responses to inform and refine our strategies moving forward. Our member agencies, from over a dozen countries, also shared the latest healthcare trends in their markets.
Most importantly, today is World Rare Disease Day and because of this we spent the greater part of the morning discussing the cold hard fact that medical research innovations alone cannot help patients with rare medical conditions. Our keynote speaker, David Kwasha, Managing Director of Alexion Pharmaceuticals, delivered a powerful message and queried why patients should be denied access to treatments for rare diseases. “Why should any human be discriminated against access to life-saving therapy simply because their disease is ultra-rare? Considering the majority of ultra-rare diseases are often the most life-threatening diseases seen in medicine, and commonly affect infants, children and young adults, we need much greater collaboration between government, industry and the general public in this exciting era in which science is unlocking breakthroughs,” said Mr Kwasha. He challenged partners to devise effective communications-driven strategies to address the dilemma of reimbursement for treatments for ultra-rare disease.
Exactly four weeks from today, our health communications executives from over a dozen countries will gather in Sydney, Australia for the 14th annual GLOBALHealthPR Annual General Meeting (AGM). Chaired by Spectrum, GLOBALHealthPR is the largest privately-held organization dedicated exclusively to science and health communications worldwide. Our partners at VIVA! Communications will host the meeting, andwe can’t wait to attend. [Read more…] about Down Under to Discuss What’s Up in Health and Science Communications
Principals of GLOBALHealthPR public relations firms gathered in Lisbon, Portugal, this week for our annual general meeting, hosted for 2013 by Guess What and one of its founders, Jorge Azevedo.
No doubt that the Spectrum team is having an amazing, enriching time in Brazil. We’ve been indulging in the local cuisine, exploring the diverse city and playfully dodging the obstacles that rainy weather brings to São Paulo. It is day two of official AGM business, and we’ve been having some really productive conversations about the Network and our vision for the future. [Read more…] about 2012 GLOBALHealthPR AGM: It’s Our Move
After a bumpy, stop-and-go cab ride from the airport and getting lost in what I’ve come to realize is one of the largest, sprawling cities (more than 8.5 times the area of Washington, D.C.), we arrived safe and sound at our hotel in the Pinheiros district of São Paulo.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.